ARTICLE
|
doi:10.20944/preprints202405.2086.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
lung cancer; type 2 diabetes mellitus; insulin therapy; Non-Insulin Antidiabetic Agents; Glucagon-Like Peptide-1 Receptor Agonists; Cancer Risk Reduction; Retrospective Cohort Study
Online: 31 May 2024 (08:10:28 CEST)